Infection is one of the leading causes of perinatal mortality worldwideaccounting for 36% of cases. Perinatal mortality in Latvia is slowly decreasing: from 7.3 per 1000 live births in 2013 to 6.7 per 1000 live births in 2015. Intrauterine infection still is a global problem and a significant factor that affects morbidity and mortality of the mother and the child.This study includes data about the cause of death, including infections, from 417 autopsy protocols of all fetuses and neonates between 22 weeks of gestation and < 7 days postpartum from 2013 to 2015.The main cause of perinatal mortality was antenatal fetal asphyxia in 50% (n=210), followed by infections -39% (n=163), including cases of chorioamnionitis. The highest mortality rate was found in the 22 nd -27 th+6 (i.e. 27 full weeks and 6 days) gestational weeks -32% of cases (n=135). Intrauterine pneumonia accounted for 24% (n=39) of all the infection caused deaths, meconium aspiration pneumonia -0.04% (n=6), early neonatal sepsis -0.03% (n=4) and specific infections like syphilis and cytomegalovirus -0.02% (n=3). Histological examination of the placenta, the placental cord and fetal membranes was made in 61% (n=255) of cases, and 19.6% (n=50) of them had an infection.
Summary Introduction. Uterine rupture is a tearing of uterine wall during pregnancy or delivery. There are two types of uterine rupture described in literature: symptomatic (SUR) and asymptomatic (AUR) uterine rupture. In case of SUR there is a full thickness uterine wall tear which leads to clinical symptoms and high perinatal and maternal morbidity and mortality. In case of AUR the visceral peritoneum remains intact and it is typically diagnosed during Cesarean section. Rupture of previously intact uterus is very rare and is associated with extensive uterine damage, severe hemorrhage and in most cases leads to hysterectomy. Fetal complications include admission to neonatal intensive care unit, hypoxic - ischemic injury and death. Maternal complications include hemorrhage, hypovolemic shock, bladder injury, hysterectomy and maternal death. The incidence and prevalence of uterine rupture as well as the perinatal and maternal rate of complications in Latvia is unknown. Aim of the Study. Aim of the study is to analyze clinical cases of SUR and AUR, calculate the incidence and prevalence and detect the risk factors (RFs) and diagnostic difficulties of clinical cases which occurred in Riga Maternity Hospital from year 2010 to 2017. Material and methods. A case series study of 41 uterine ruptures which occurred in Riga Maternity Hospital from the 1st of January 2010 until the 31st of December 2016 was performed. An average birth rate for this time period was 6554 live births per year. Results. Over the time period 41 women with uterine rupture were diagnosed in Riga Maternity Hospital. AUR was diagnosed in 33 patients during Cesarean section. SUR occurred in seven patients, but in total there were eight cases of SUR, because one of the patients had a uterine rupture twice. SUR incidence in Riga Maternity Hospital is 1.7 per 10000 deliveries (8 per 45875 deliveries) and the prevalence is 0.0175%. In three cases SUR was diagnosed after labor and in five cases - during emergency laparotomy. SUR most frequently manifested with hypovolemic shock and/or acute abdomen. In two cases uterine defect was repaired and in six cases hysterectomy was performed. One patient had acute kidney injury and there was one case of maternal death. Nine babies were delivered and the Apgar score after the 1st minute was ≥ 7 in three cases and < 7 in three cases, but after the 5th minute it was ≥ 7 in five cases and <7 in one case. There were three intrauterine fetal demises. All the patients with either SUR or AUR had multiple RFs for uterine rupture. Conclusions. Uterine rupture is associated with multiple RFs. If trial of labor after Cesarean section is the preferred mode of delivery it is necessary to detect all of the RFs. Antenatal measurement of lower uterine segment thickness seems unreliable but further research should be carried out with statistical data analysis. For the safety of patients trial of vaginal delivery in patient with uterine scar should be performed in appropriately equipped and staffed medical facilities.
Necrotising enterocolitis (NEC) is one of the leading causes of neonatal morbidity, mortality and surgical emergencies. As the survival rate of extremely low birth weight (ELBW) infants is rising, so is the risk of NEC. The aim of this study was to compare diagnostics parameters like clinical and radiological findings and laboratory indicators and the treatment and outcome of NEC patients from 2000 till 2007 (Group 1) and from 2008 till 2016 (Group 2) treated in Neonatology Clinic (NC) of Children’s Clinical University Hospital (CCUH). In the rectrospective study, 277 newborns were divided among Group I and Group II – 105 and 172 patients, respectively. There were no statistically significant differences between both study groups in mean gestational age and birth weight. In both groups the first signs of NEC appeared on average eight days after birth. Differences in the diagnostic method used in both groups were not statistically significant; specific radiological findings were seen in approximately 1/3 of the cases. There were statistically significant differences in the management of NEC and patient mortality. Conservative therapy was applied in 70.0% of patients in both study groups. Over time, peritoneal drainage (PPD) as the sole surgical treatment decreased by 6.4%, but PPD with following enterostomy decreased by 8.9%. In Group 2 mortality of NEC patients decreased by 17.4%. Mortality among surgically treated NEC patients decreased as well, by 9.0%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.